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Abstract
Hospital-acquired pneumonia is a serious and potentially life-
threatening complication, with reported pneumonia-attributable
mortality rates as high as 50%. Rapid diagnosis and immediate
institution of adequate empirical antimicrobial treatment are of
paramount importance in patient management. Nevertheless, some
patients deteriorate and develop respiratory insufficiency, septic
shock and a multiorgan dysfunction syndrome. Early recognition of
these patients might help in reducing morbidity and mortality.
Elevated systemic levels of proinflammatory cytokines (IL-1β, IL-6,
IL-8 and IL-10) at the time of diagnosis of hospital-acquired
pneumonia appear to be indicative of subsequent progression to
septic shock. Should this now become a part of patient
management?
In the present issue of Critical Care, van Dossow and
coworkers [1] report their findings in predicting progression
from hospital-acquired pneumonia (HAP) to septic shock
based on systemic levels of proinflammatory cytokines at the
time of HAP diagnosis. They evaluated 76 patients with a
clinical diagnosis of HAP, of whom 29 (38%) progressed to
septic shock. Systemic levels of IL-1β, IL-6, IL-8 and IL-10 at
the time of diagnosis were higher in patients who subsequently
progressed to septic shock. Moreover, these systemic levels
predicted disease progression better than do currently used
parameters such as C-reactive protein and leucocyte counts in
peripheral blood. Before we modify our daily practice in
accordance with these interesting findings, we must consider
whether the data were rigorously obtained, are generalizable
and are likely to improve the standard of care.
The spectrum of pneumonia has been divided into three
areas, with similar sounding acronyms. HAP is defined as
pneumonia diagnosed 48 hours or more after hospital
admission, without clinical signs of pneumonia at the time of
admission. If such signs are present and pneumonia is
diagnosed within 48 hours after admission, then it is termed
community-acquired pneumonia. If a patient has already been
receiving mechanical ventilatory support for more than
48 hours at the time of diagnosis, then it is termed ventilator-
associated pneumonia (VAP). To make matters even more
confusing, VAP has been divided into early-onset VAP
(occurring within the first 4 days of ventilation or
hospitalization) and late-onset VAP (occurring thereafter).
Early-onset VAP is more likely to be caused by antibiotic-
sensitive bacteria and is considered to carry a better
prognosis than late-onset VAP, which is frequently caused by
multidrug resistant pathogens [2]. HAP occurs at a rate of
5–10 cases per 1000 hospital admissions, with the
incidence increasing as much as 6-fold to 20-fold in
mechanically ventilated patients [3]. So what types of
pneumonia were evaluated in the study conducted by van
Dossow and coworkers? All patients underwent surgery, and
the average time between hospital admission and the
diagnosis of pneumonia was 42 and 33 hours for patients
developing and not developing septic shock, respectively. In
addition, all patients were mechanically ventilated at some
point, although it remains unclear whether patients needed
ventilatory support because of pneumonia or were still
receiving mechanical ventilation after surgery at the time of
diagnosis. Assuming that patients were hospitalized because
of surgical procedures, and not because of community-
acquired pneumonia, a considerable proportion of the
patients should probably be categorized as very early-onset
VAP. Microbial aetiology and appropriateness of empirical
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antibiotic therapy are important prognostic variables in
nosocomial pneumonia. Unfortunately, the microbiological
data provided are rather nonspecific. Gram-positive bacteria
more frequently caused pneumonia that did not progress to
septic shock (86% of cases with 100% survival), whereas
47% of patients developing septic shock were infected with
Gram-negative bacteria (survival 55%). Moreover, 12 patients
(16%; five without and seven with subsequent shock) did not
initially receive appropriate therapy, which was changed
when cultures became available. However, no differences in
outcome or inflammatory parameters could be discerned
between these patients.
Did all patients truly have pneumonia? Diagnosing
nosocomial pneumonia is difficult and is usually based on the
presence of a new or progressive radiographic infiltrate along
with clinical findings suggesting infection, such as fever,
purulent sputum, leucocytosis and decline in oxygenation.
The combination of these criteria has a high sensitivity, but
specificity is rather low. More specific diagnostic approaches
are needed, especially in mechanically ventilated patients, in
whom abnormalities on chest radiography may also result
from noninfectious causes (such as atelectasis, congestive
heart failure, pulmonary embolism with infarction, lung
contusion [in trauma patients] and chemical pneumonitis after
aspiration). For such patients the best evaluated approach is
use of invasive diagnostic techniques (in order to avoid
sampling of the colonized upper respiratory tract) with
quantitative microbiological cultures (in order to distinguish
true infection from procedure-related contamination). In the
only prospective randomized trial evaluating both approaches
[4], the clinical suspicion of VAP was not confirmed by
quantitative cultures in approximately 50% of patients and
antibiotics were withheld in most of them. However, despite
withholding of antibiotics in a considerable fraction of
patients, survival was better among patients randomly
assigned to the invasive diagnostic strategy. Importantly, in
the study conducted by van Dossow and coworkers [1],
pneumonia was diagnosed based on a combination of
radiographic and clinical criteria (as mentioned above) and
some patients might have been misclassified as having
pneumonia. Although patients with cardiac problems and
acute lung injury were excluded, the diagnostic strategy used
does not rule out alternative infections or noninfectious foci.
Therefore, one could ask whether clinical deterioration truly
resulted from pneumonia in all patients.
So, can we predict deterioration of HAP to septic shock
using biochemical means? Taking into account all of the
considerations mentioned above, in their study van Dossow
and coworkers [1] were able to distinguish between patients
who developed and those who did not develop septic shock
based on systemic levels of proinflammatory cytokines, while
currently used variables (such as C-reactive protein) could
not. However, bedside determination of interleukins using
enzyme-linked immunosorbent assay is still far from common
clinical practice. Even if this were possible, what potential
clinical consequences could be identified based on elevated
cytokine levels if the diagnosis of pneumonia has been firmly
established with other sources of infections excluded, if the
causative pathogens have been isolated and if appropriate
antimicrobial therapy has been instituted? There is no current
evidence that immunomodulation (e.g. with corticosteroids)
or sepsis treatment (e.g. with activated protein C) would
prevent disease progression in such patients. However,
reliable tools with which to predict disease progression
would be the first step in establishing a new field of infectious
disease management in critically ill patients.
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